Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application Research of Hydromorphinone Sustained-release Tablets in the Treatment of Elderly Patients With Cancer Pain Accompanied by Renal Insufficiency

NCT07421674 is registered in ClinicalTrials.gov with Taian Cancer Hospital as lead sponsor.

NCT NCT07421674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application Research of Hydromorphinone Sustained-release Tablets in the Treatment of Elderly Patients With Cancer Pain Accompanied by Renal Insufficiency
Lead sponsor
Taian Cancer Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 10, 2026
Completion date
December 31, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain, hydromorphone use, renal insufficiency chronic